Cargando…
Developments and opportunities in continuous biopharmaceutical manufacturing
Today’s biologics manufacturing practices incur high costs to the drug makers, which can contribute to high prices for patients. Timely investment in the development and implementation of continuous biomanufacturing can increase the production of consistent-quality drugs at a lower cost and a faster...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043180/ https://www.ncbi.nlm.nih.gov/pubmed/33843449 http://dx.doi.org/10.1080/19420862.2021.1903664 |